These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12092437)

  • 21. [Cause of familial multiple sclerosis].
    Wender MB
    Wiad Lek; 2002; 55(5-6):351-3. PubMed ID: 12235705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and current treatment of multiple sclerosis in Europe today.
    Pozzilli C; Romano S; Cannoni S
    J Rehabil Res Dev; 2002; 39(2):175-85. PubMed ID: 12051462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
    Grapsa E; Triantafyllou N; Rombos A; Lagouranis A; Dimopoulos MA
    Ther Apher Dial; 2008 Apr; 12(2):105-8. PubMed ID: 18387157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferons in multiple sclerosis: ten years' experience.
    Tourbah A; Lyon-Caen O
    Biochimie; 2007; 89(6-7):899-902. PubMed ID: 17574320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review.
    Amaria RN; Corboy JR; Finlayson CA; Robinson WA; Borges VF
    Clin Breast Cancer; 2008 Oct; 8(5):449-52. PubMed ID: 18952560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and disease modifying treatments in multiple sclerosis.
    Zajicek J
    Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical consultations: multiple sclerosis.
    Wingerchuk DM; Carter JL
    Semin Neurol; 2003 Sep; 23(3):253-64. PubMed ID: 14722821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment.
    Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific treatment of multiple sclerosis.
    Silberberg DH
    Clin Neurosci; 1994; 2(3-4):271-4. PubMed ID: 7749898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study.
    Webb UH
    J Neurosci Nurs; 2008 Dec; 40(6):356-61. PubMed ID: 19170303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and multiple sclerosis.
    Houtchens MK
    Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis.
    Blumenthal S
    Radiol Technol; 2006; 77(4):309-21, quiz 322-5. PubMed ID: 16543484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis. Primary health care implications.
    Swain SE
    Nurse Pract; 1996 Jul; 21(7):40, 43, 47-50 passim. PubMed ID: 8823787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients].
    Schilling S; Linker RA; König FB; Koziolek M; Bähr M; Müller GA; Paulus W; Gärtner J; Brück W; Chan A; Gold R
    Nervenarzt; 2006 Apr; 77(4):430-8. PubMed ID: 16341736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rapid modification of the symptomatology of progressive forms of multiple sclerosis by plasma exchange].
    Trouillas P; Neuschwander P; Trémisi JP
    Rev Neurol (Paris); 1986; 142(8-9):689-95. PubMed ID: 3809855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.